Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DIAZEPAM CRS - * PSY (10 MG)

DIAZEPAM CRS - * PSY (10 MG)

439-14-5

DISCOVER
DIAZOXIDE CRS (50 MG)

DIAZOXIDE CRS (50 MG)

364-98-7

DISCOVER
DIBENZOCYCLOHEPTENE CRS (20 MG)

DIBENZOCYCLOHEPTENE CRS (20 MG)

256-81-5

DISCOVER
DIBENZOSUBERONE CRS (30 MG)

DIBENZOSUBERONE CRS (30 MG)

1210-35-1

DISCOVER
DIBUTYL PHTHALATE CRS (1 ML)

DIBUTYL PHTHALATE CRS (1 ML)

84-74-2

DISCOVER
DICLOFENAC POTASSIUM CRS (70 MG)

DICLOFENAC POTASSIUM CRS (70 MG)

15307-81-0

DISCOVER
Dimethylphenol-2,3

Dimethylphenol-2,3

526-75-0

DISCOVER
DICLOXACILLIN SODIUM CRS (250MG)

DICLOXACILLIN SODIUM CRS (250MG)

13412-64-1

DISCOVER
DICYCLOVERINE HYDROCHLORIDE CRS (100 MG)

DICYCLOVERINE HYDROCHLORIDE CRS (100 MG)

67-92-5

DISCOVER
Dienestrol CRS, 150mg

Dienestrol CRS, 150mg

84-17-3

DISCOVER
DIETHYLCARBAMAZINE CITRATE CRS (250 MG)

DIETHYLCARBAMAZINE CITRATE CRS (250 MG)

1642-54-2

DISCOVER
Diazepam C-IV

Diazepam C-IV

439-14-5

DISCOVER